Stay updated on Upadacitinib in Giant Cell Arteritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.

Latest updates to the Upadacitinib in Giant Cell Arteritis Clinical Trial page
- Check5 days agoChange DetectedA full Locations section was added, enumerating study sites across the United States, Canada, Europe, Australia, and other regions. This provides clear access to where the trial is being conducted.SummaryDifference4%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no visible changes to study details or page navigation.SummaryDifference0.0%

- Check34 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed and may not be about the study, and updated the revision to v3.3.1. Removed the older PubMed attribution text and updated to v3.2.0.SummaryDifference0.3%

- Check41 days agoChange DetectedRemoved the notice about government funding delays and NIH operating status. The study details on the page remain unchanged.SummaryDifference0.1%

- Check55 days agoChange DetectedNo significant changes detected in the study record; core content such as study design, eligibility criteria, interventions, outcomes, and location lists appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check84 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in Giant Cell Arteritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.